Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 27, 2022, titled "Tergene Biotech Pvt. Ltd., a Joint Venture company, receives SEC recommendation for pneumococcal 15 valent (PCV15) vaccine.".
Press Release Dec 27 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Nov 23 2022
- Press Release Nov 18 2022
- Press Release Nov 12 2022
- Press Release Aug 24 2022
- Press Release Aug 16 2022
Later from Aurobindo Pharma
- Press Release (Revised) Jan 04 2023
- Press Release Feb 07 2023
- Aurobindo Pharma Ltd Press Release Mar 08 2023
- Press Release Mar 30 2023
- Press Release May 26 2023
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma